rs41265094

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_005544.3(IRS1):​c.2452G>C​(p.Gly818Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0117 in 1,613,528 control chromosomes in the GnomAD database, including 145 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0081 ( 11 hom., cov: 33)
Exomes 𝑓: 0.012 ( 134 hom. )

Consequence

IRS1
NM_005544.3 missense

Scores

1
7
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.69

Publications

13 publications found
Variant links:
Genes affected
IRS1 (HGNC:6125): (insulin receptor substrate 1) This gene encodes a protein which is phosphorylated by insulin receptor tyrosine kinase. Mutations in this gene are associated with type II diabetes and susceptibility to insulin resistance. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008466393).
BP6
Variant 2-226796287-C-G is Benign according to our data. Variant chr2-226796287-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 402985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 1230 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IRS1NM_005544.3 linkc.2452G>C p.Gly818Arg missense_variant Exon 1 of 2 ENST00000305123.6 NP_005535.1 P35568
IRS1XM_047444223.1 linkc.2452G>C p.Gly818Arg missense_variant Exon 1 of 2 XP_047300179.1
IRS1XM_047444224.1 linkc.2452G>C p.Gly818Arg missense_variant Exon 1 of 2 XP_047300180.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IRS1ENST00000305123.6 linkc.2452G>C p.Gly818Arg missense_variant Exon 1 of 2 1 NM_005544.3 ENSP00000304895.4 P35568

Frequencies

GnomAD3 genomes
AF:
0.00808
AC:
1230
AN:
152240
Hom.:
11
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00215
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.00432
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00228
Gnomad FIN
AF:
0.0178
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0122
Gnomad OTH
AF:
0.00907
GnomAD2 exomes
AF:
0.00828
AC:
2075
AN:
250672
AF XY:
0.00806
show subpopulations
Gnomad AFR exome
AF:
0.00218
Gnomad AMR exome
AF:
0.00318
Gnomad ASJ exome
AF:
0.00407
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0203
Gnomad NFE exome
AF:
0.0114
Gnomad OTH exome
AF:
0.0101
GnomAD4 exome
AF:
0.0121
AC:
17692
AN:
1461170
Hom.:
134
Cov.:
41
AF XY:
0.0119
AC XY:
8652
AN XY:
726872
show subpopulations
African (AFR)
AF:
0.00170
AC:
57
AN:
33480
American (AMR)
AF:
0.00347
AC:
155
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00383
AC:
100
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00307
AC:
265
AN:
86252
European-Finnish (FIN)
AF:
0.0203
AC:
1068
AN:
52716
Middle Eastern (MID)
AF:
0.00330
AC:
19
AN:
5766
European-Non Finnish (NFE)
AF:
0.0139
AC:
15413
AN:
1112006
Other (OTH)
AF:
0.0102
AC:
615
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1156
2312
3468
4624
5780
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
598
1196
1794
2392
2990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00807
AC:
1230
AN:
152358
Hom.:
11
Cov.:
33
AF XY:
0.00825
AC XY:
615
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.00214
AC:
89
AN:
41588
American (AMR)
AF:
0.00431
AC:
66
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00228
AC:
11
AN:
4828
European-Finnish (FIN)
AF:
0.0178
AC:
189
AN:
10626
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0122
AC:
830
AN:
68034
Other (OTH)
AF:
0.00898
AC:
19
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
67
134
202
269
336
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0114
Hom.:
4
Bravo
AF:
0.00734
TwinsUK
AF:
0.0159
AC:
59
ALSPAC
AF:
0.0145
AC:
56
ESP6500AA
AF:
0.00318
AC:
14
ESP6500EA
AF:
0.0128
AC:
110
ExAC
AF:
0.00815
AC:
989
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.0114
EpiControl
AF:
0.0116

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

-
Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

IRS1: BP4, BS1, BS2 -

Type 2 diabetes mellitus Benign:2
Jan 03, 2017
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Dec 17, 2014
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Has been reported in a patient with NIDDM. 2% MAF. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.56
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.37
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.56
D
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.45
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.82
T
MetaRNN
Benign
0.0085
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
1.7
L
PhyloP100
2.7
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
-1.5
N
REVEL
Benign
0.23
Sift
Benign
0.095
T
Sift4G
Uncertain
0.052
T
Polyphen
1.0
D
Vest4
0.64
MutPred
0.56
Gain of solvent accessibility (P = 6e-04);
MVP
0.85
MPC
1.0
ClinPred
0.012
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.17
gMVP
0.28
Mutation Taster
=85/15
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41265094; hg19: chr2-227661003; COSMIC: COSV99043455; COSMIC: COSV99043455; API